Cirqle Biomedical Secures Pre-Seed Funding for Next Generation Contraceptive - Business Wire

Cirqle Biomedical Secures Pre-Seed Funding for Next Generation Contraceptive  Business Wire

Cirqle Biomedical today announced that it has secured $1.8M for pre-clinical development of a novel non-hormonal contraceptive technology.


Comments

Popular Posts

Community-Acquired Pneumonia: Symptoms and Treatment - Verywell Health

Dengue – the Region of the Americas - World Health Organization